The oversubscribed round was co-led by Forbion, FMC Ventures, and Corteva Inc.
SOLASTA Bio
SOLASTA Bio develops green peptide-based insecticides for agricultural use.
SOLASTA Bio develops nature-inspired peptide-based insecticides designed to protect crops while preserving pollinators.
Filed accounts
Cash at bank
Net current assets
Total assets less current liabilities
Shareholders' funds
Fixed assets
Current assets
Cash, assets and headcount from SOLASTA Bio's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders

Shireen Davies
CEO
Shireen serves as chief executive officer and founder of SOLASTA Bio, following an academic career as a professor at the University of Glasgow.
LinkedInPaul Bernasconi
Chief Technology Officer
Paul cofounded SOLASTA Bio, where he serves as chief operating officer. He previously headed molecular biology at BASF Plant Science and currently advises Oerth Bio.
LinkedInInvestors
- $14.0MFForbionLeadFVFMC VenturesLeadCCortevaLeadCVCavallo VenturesFollow-onRIRubio Impact VenturesFollow-onScottish EnterpriseFollow-on
SIS VenturesFollow-on
- £4.0M
Funding history
Yield Lab Europe led the pre-Series A round, which will fund international expansion and team growth.
